What is e-consent, and why is it important in clinical trials?

E-consent is the electronic method of obtaining informed consent from participants in clinical trials. It simplifies the consent process by allowing participants to review information, ask questions, and provide consent digitally. This method ensures that participants fully understand the trial requirements and risks, while improving efficiency and reducing errors in documentation. E-consent is particularly useful in remote or complex trials, offering real-time tracking, compliance, and audit-readiness, which enhances both participant engagement and trial management.

How does e-consent improve participant engagement in clinical trials?

E-consent enhances participant engagement by providing interactive, user-friendly digital platforms that include multimedia elements such as videos and diagrams to explain complex trial information. Participants can review the consent forms at their own pace, access additional resources, and communicate with trial staff for clarification. This improved understanding of the trial details can lead to higher retention rates, as participants feel more informed and confident in their decision to take part.

What are the compliance and regulatory benefits of using e-consent in clinical research?

E-consent platforms ensure compliance with global regulatory requirements by documenting the entire consent process, capturing digital signatures, and providing real-time audit trails. This transparency ensures that the correct consents are obtained for each stage of a trial and that no steps are missed. Additionally, e-consent platforms can facilitate re-consent when necessary, ensuring that any protocol changes are clearly communicated to participants and that their continued consent is recorded.

How does e-consent streamline the re-consent process?

In clinical trials, re-consent may be necessary if there are protocol changes or new findings that affect participants. E-consent platforms streamline this process by enabling immediate communication with participants, offering updated consent forms digitally, and tracking their responses in real time. This eliminates delays and ensures that participants remain fully informed, compliant, and able to continue the trial without unnecessary interruptions or confusion.

What are the cost-saving advantages of implementing e-consent systems in clinical trials?

E-consent systems reduce costs associated with paper-based documentation, printing, and physical storage. They also decrease the need for in-person consent procedures, which can be logistically challenging, especially in large-scale or decentralised trials. By automating consent tracking, reducing errors, and minimising the need for repeat consents, e-consent platforms improve overall trial efficiency, saving time and resources for both sponsors and clinical sites.

e-Consent

Buyer's Guides

Econsent Vendors and Companies for Clinical Trials

Free Buyers Guide Econsent Vendors and Companies for Clinical Trials The document includes detailed information on the manufacturers and suppliers…

Elli Karampela

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Econsent Vendors and Companies for Clinical Trials

Leading Strategic Intelligence Solutions for the Clinical Trials Industry

Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing